Venture Capital

Moonwalk Biosciences: Genomic Medicine Company Raises $57 Million

By Noah Long ● Jan 5, 2024

Moonwalk Biosciences - a genomic medicine company pioneering precision epigenetic medicines - recently announced the completion of $57 million in seed and Series A financing from Alpha Wave Ventures, ARCH Venture Partners, Future Ventures, GV, Khosla Ventures and YK Bioventures. The funding will support the continued advancement of Moonwalk’s epigenetic profiling and engineering technology platform and progress its pipeline of epigenetic therapeutics toward the clinic.

Reimagine Care: Strategic Investment From Oncology Ventures Raised

By Noah Long ● Jan 5, 2024

Reimagine Care - a leading provider of virtual-first cancer care - recently announced an investment from Oncology Ventures, a cancer-focused venture capital fund. This funding round marks a significant milestone in the combined pursuit of innovative and patient-centric approaches to cancer care delivery.

Happy Money Signs Strategic Deal With TruStage

By Annie Baker ● Jan 5, 2024

Happy Money - a leading platform for unsecured lending in partnership with credit unions - recently announced the close of a strategic transaction led by TruStage Ventures and other institutional investors. Happy Money remains a privately held company with independent operations under CEO Joe Heck.

Arbital Health: $10 Million Funding And Santa Barbara Actuaries Acquisition

By Dan Anderson ● Jan 5, 2024

Arbital Health - a technology startup focused on accelerating the healthcare industry's transition to value-based care - recently announced the acquisition of Santa Barbara Actuaries and $10 million in Series A financing led by digital healthcare investor Transformation Capital.

Chai: Social AI Platform Company Raises Funding At $450 Million Valuation

By Annie Baker ● Jan 5, 2024

AI platform Chai announced that CoreWeave (the leading specialized GPU cloud provider) will invest in the company, placing Chai at a $450 million valuation. This deal followed shortly after Chai's initial fundraising in June 2023, bringing the total capital invested in Chai to over $10 million.

Exponent Founders Capital Launched With $125 Million To Invest In Early-Stage Companies

By Amit Chowdhry ● Jan 5, 2024

Early stage venture capital firm Exponent Founders Capital launched and disclosed it has raised $125 million to date, including a new $75 million Fund II vehicle that will be deployed across promising inception and early stage companies spanning enterprise software, fintech and payments, infrastructure, applied AI, and vertical SaaS throughout the U.S., Canada, and Europe.

Stanford Byers Center for Biodesign Co-Founder Dr. Josh Makower Joins Sofinnova Partners

By Amit Chowdhry ● Jan 5, 2024

Sofinnova Partners - a leading European life sciences venture capital firm based in Paris, London, and Milan - recently announced that Dr. Joshua Makower, co-founder and director of the Stanford Byers Center for Biodesign, has joined Sofinnova as an advisory Venture Partner.

HI-Bio: $95 Million Raised To Develop Targeted Therapies For Immune-Mediated Diseases

By Amit Chowdhry ● Jan 5, 2024

Human Immunology Biosciences (HI-Bio) - a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs) - recently announced the closing of a $95 million Series B financing led by new investor Alpha Wave Global. Viking Global Investors and Arkin Bio Capital participated in the financing, and existing investors Jeito Capital and ARCH Venture Partners.

VMocion: $3 Million Raised To Improve Virtual Motion Technologies

By Annie Baker ● Jan 5, 2024

VMocion - an entertainment technology company based in Scottsdale, Arizona - recently announced a $3 million seed round for the advancement of its VMocion 3V and WAIV technologies.

UrbanStems: Modern Floral Gifting Company Secures $5 Million In Funding

By Annie Baker ● Jan 5, 2024

UrbanStems - a premier modern floral gifting company - recently announced that it has secured $5 million in Series C extension funding from existing investors. The funding fuels the company's growth strategy as it expands same-day delivery service to new cities across the U.S.

Goldman Sachs Asset Management: $650 Million Raised For West Street Life Sciences I Fund

By Amit Chowdhry ● Jan 5, 2024

Goldman Sachs Asset Management recently announced the final close of West Street Life Sciences I, representing the first fund in the firm’s Life Sciences Investing strategy. Life Sciences I closed above the fundraising target, with $650 million in equity commitments from a global, diverse group of institutional, strategic and high net worth investors and meaningful commitment from Goldman Sachs employees. The fund raise is one of the largest ever first-time private life sciences growth funds.

Vigilant Ops: SBMOM Automation Company Closes $2 Million In Funding

By Dan Anderson ● Jan 5, 2024

DataTribe - a global cyber foundry that invests in and co-builds next-generation cybersecurity and data science companies - recently announced a $2 million seed investment in Vigilant Ops, a leading automation platform for the generation, maintenance, and authenticated sharing of certified Software Bill of Materials (SBOM). Vigilant Ops (winner of the 6th annual DataTribe Challenge in November) performs continuous vulnerability monitoring and alerting, security patch notifications, and the ability to upload SBOMs - lists of the software libraries embedded in products - from alternate sources.

Perplexity: AI Search Company Raises $73.6 Million At A Reported $520 Million Valuation

By Amit Chowdhry ● Jan 5, 2024

Perplexity recently announced milestones reinforcing the company’s increasingly dominant role in this new era of AI-native search. Since publicly launching the world’s first fully functional conversational answer engine about a year ago, the company has grown to 10 million monthly active users and served over half a billion queries last year.

Ceretype Neuromedicine: Functional MRI Company Raises $2 Million

By Noah Long ● Jan 5, 2024

Ceretype Neuromedicine - a pioneer in the practical application and integration of functional MRI (fMRI) - recently announced that it has closed its second round of seed financing. And the company’s $2 million funding target was oversubscribed.

Forward Consumer Partners: Debut Fund Closed At $425 Million Hard Cap

By Amit Chowdhry ● Jan 4, 2024

Forward Consumer Partners - a private equity firm that invests in branded consumer businesses - announced recently the successful closing of its oversubscribed debut fund, Forward Fund I (Fund I).

Vasa Therapeutics Raises $6 Million In Seed Funding To Develop Therapies For Cardiovascular Aging Diseases

By Dan Anderson ● Jan 4, 2024

Vasa Therapeutics - a preclinical stage biopharmaceutical company developing novel therapies for cardiovascular aging - recently announced the closing of $6 million in series seed funding led by Orphinic Scientific SA. The funding round also included participation from private investment funds NuFund Venture Group, SeedFolio, and others.

Radionetics Oncology: $52.5 Million Secured To Advance Radiopharmaceutical Pipeline

By Annie Baker ● Jan 4, 2024

Radionetics Oncology - a clinical-stage radiopharmaceutical company focused on discovering and developing novel agents for treating a wide range of oncology indications - recently announced the completion of a $52.5 million Series A financing. The funding round was led by Frazier Life Sciences, 5AM Ventures, and new investor, DCVC Bio, with participation from Crinetics Pharmaceuticals and GordonMD Global Investments, raising the total to $82.5 million.

Aqua Security: $60 Million Funding Raised At Over $1 Billion Valuation

By Amit Chowdhry ● Jan 4, 2024

Aqua Security - a pioneer in cloud-native security - recently announced it had secured $60 million in funding, led by new investor Evolution Equity Partners, with participation from existing investors Insight Partners, Lightspeed Venture Partners, and StepStone Group. The funding - which is an extension of the company’s Series E round - placed Aqua’s valuation above $1 billion.

Vita Inclinata: $44 Million Closed To Create A Safety Ecosystem For Rescue Crews

By Noah Long ● Jan 4, 2024

Vita Inclinata Technologies - an innovator in intelligent lifting hardware and software for rescue crews and other field safety applications - recently announced that it secured $44 million in funding from 3&1 Fund, a global leader in IP (Intellectual Property) based financing solutions. Utilizing a debt structure, 3&1 Fund offered a compelling alternative to traditional equity-based venture capital financing, which will boost Vita Inclinata Technologies' expansion initiatives.

Remix Therapeutics: $60 Million Raised To Develop Small Molecule Therapies To Modulate RNA Processing

By Amit Chowdhry ● Jan 4, 2024

Remix Therapeutics - a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying drivers of disease - recently announced closing a $60 million financing led by The Column Group.

BioCentriq: Cell-Based Therapy CDMO Company Secures $29.2 Million

By Annie Baker ● Jan 4, 2024

BioCentriq - a global cell-based therapy Contract Development and Manufacturing Organization (CDMO) - recently announced the successful completion of its latest round of fundraising, securing $29.2 million in capital investment. The funding round presents a significant milestone in BioCentriq's mission to accelerate the delivery of innovative cell therapies by translating, optimizing, and scaling processes for GMP manufacture.

NewSpring: Fourth Growth Equity Healthcare Fund Exceeds Target At Over $180 Million

By Amit Chowdhry ● Jan 3, 2024

NewSpring - a family of private equity strategies investing in the lower-middle market - recently announced the final close of its oversubscribed fourth healthcare fund NewSpring Health Capital IV (NSH IV), raising over $180 million.

Robin AI: Legal Copilot Company Secures $26 Million

By Noah Long ● Jan 3, 2024

Luna: $50 Million In Funding And Silixa Acquisition

By Amit Chowdhry ● Jan 3, 2024

Luna Innovations - a global leader in advanced fiber optic-based technology - recently announced a $50 million investment by White Hat Capital Partners, an investment firm focused on sustainable value creation in technology companies serving mission-critical applications. The proceeds from this strategic investment were partially used to fund the acquisition of Silixa and related transaction costs in the aggregate amount of approximately $25 million.

Shield AI: Aircraft AI Pilot Company Expands Series F Funding Round To $500 Million

By Amit Chowdhry ● Jan 3, 2024

Shield AI - a defense technology company building the best AI pilot for aircraft - recently announced the expansion of their Series F funding round to $500 million. An additional $100 million in equity, raised at the Series F price, and $200 million in debt from Hercules Capital were added to the initial $200 million in equity closed in November.

Heranova Lifesciences: $13.5 Million Raised To Develop Women’s Health Solutions

By Annie Baker ● Jan 3, 2024

Heranova Lifesciences Holding Ltd. recently announced the successful completion of a $13.5 million seed and seed+ financing to develop and offer integrated Women's Health solutions worldwide. This funding round will be used to launch a series of non-invasive endometriosis tests and advance two innovative (non-hormonal and non-antibiotic) therapeutic programs for endometriosis and bacterial vaginosis.

ImmunityBio: Up To $320 Million Investment Being Provided By Oberland Capital

By Amit Chowdhry ● Jan 2, 2024

ImmunityBio - a clinical-stage immunotherapy company- announced today an up to $320 million royalty financing and equity investment in the company by Oberland Capital, with $210 million of gross proceeds received at closing on December 29, 2023. The additional investment provides significant financial resources for the company to accelerate its commercialization efforts in anticipation of a potential regulatory approval and expand its pipeline within the broader urological cancer space. The proceeds will also fund ongoing business operations and clinical trials expanding N-803 (Anktiva) indications into multiple solid tumors.

UltiHash: Sustainable Data Storage Solution Company Raises $2.5 Million

By Amit Chowdhry ● Jan 2, 2024

UltiHash - the first high-performance and sustainable data storage solution - recently announced it has raised $2.5 million in pre-seed funding. This funding round was led by Inventure, with participation from PreSeedVentures, Tiny VC, Futuristic VC, The Nordic Web, Antti Karjalainen (founder of Robocorp and angel scout for Sequoia Capital), and other private investors. UltiHash joined a market where data growth is skyrocketing, and the environment is being taxed for the fuel. Digital data generates a lot of carbon emissions. This rising tide of data will lift the boats with the data storage to facilitate high-performance applications like process optimization and product development.

Red Cell Partners: $91 Million Closed For Incubation Fund

By Amit Chowdhry ● Jan 2, 2024

Red Cell Partners - a McLean, VA-based incubation firm building rapidly scalable technology-led companies that are bringing advancements to market in healthcare and national security - recently announced the closing of $91 million in new capital for a new incubation fund, RCIF I. This new fund allows the firm to back incubations, raising early-stage rounds.

Devoted Health: $175 Million To Improve Medical Care For Older Americans

By Amit Chowdhry ● Jan 1, 2024

Devoted Health - an all-in-one healthcare company for Medicare beneficiaries, delivering health insurance, virtual-first medical care, and sophisticated service experience - recently announced that it has closed on $175 million of Series E funding.